Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes

7Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: To evaluate the safety profile of a brimonidine extended release intravitreal implant, in normotensive rabbit eyes. Methods: Devices were made from hollow poly-l-lactic acid (PLA) tubes and contained hundred micrograms of brimonidine pamoate. Device was injected intravitreally in one eye of 12 New Zealand pigmented rabbits, whereas other eye was injected with a sham implant in masked fashion. Ocular examination was conducted at baseline and months 1, 3 and 6 including dilated fundus examination and electro-retinogram (ERG). Four rabbits were sacrificed at each time-point for retinal histology. ERG data were compared between groups and time-points using anova. Results: No complications were reported from either eye of any rabbits over a 6-month period. Photopic A wave was reduced in the control eye at 1 month compared with baseline (p < 0.01). There was no significant difference in other ERG parameters between the groups at different time-points. Gross retinal histology was normal at all time-points. Conclusion: Extended release intravitreal brimonidine device was found to be safe and in normotensive rabbit eyes. © 2012 The Authors. Acta Ophthalmologica.

Cite

CITATION STYLE

APA

Deokule, S. P., Baffi, J. Z., Guo, H., Nazzaro, M., & Kaneko, H. (2012). Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes. Acta Ophthalmologica, 90(5). https://doi.org/10.1111/j.1755-3768.2012.02418.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free